Detection of illegal use of androgens and selective androgen receptor modulators

Testosterone: Action, Deficiency, Substitution, Fourth Edition

Volumn , Issue , 2012, Pages 517-534

  Schänzer, Wilhelm ^a   Thevis, Mario ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896756704     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139003353.025     Document Type: Chapter

References (71)

1. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B, Pope HG Jr (1996) Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrom 31: 169-176
2. Becchi M, Aguilera R, Farizon Y, Flament MM, Casabianca H, James P (1994) Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport. Rapid Commun Mass Spectrom 8: 304-308
3. Beckett AH, Cowan DA (1979) Misuse of drugs in Sport. Brit J Sports Med 2: 185-194
4. Belkien L, Schurmeyer T, Hano R, Gunnarsson PO, Nieschlag E (1985) Pharmacokinetics of 19- nortestosterone esters in normalmen. J Steroid Biochem 22: 623-629
5. Bhasin S, Jasuja R (2009) Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care 12: 232-240
6. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunell TJ, Tricker R, Shirazi A, Casaburi R (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. J Med 335: 1-7
7. Boos C, Wulff P, Kujath P, Bruch HP (1998) Medikamentenmissbrauch im Freizeitsport. Deutsches Ärzteblatt 95(16): A953-A957
8. Brooks RV, Firth R, Summer NA (1975) Detection of anabolic steroids by radio immunoassay. Br J Sports Med 9: 89-92
9. Canadian Centre for Drug-Free Sport (1993) News Release - Over 80, 000 young Canadians using anabolic steroids. CCDFS, Montreal
10. Catlin DH, Ahrens BD, Kucherova Y (2002) Detection of norbolethone, an anabolic steroid never marketed, in athletes’ urine. Rapid Commun Mass Spectrom 16: 1273-1275
11. Catlin DH, Sekera MH, Ahrens BD, Stracevic B, Chang YC, Hatton CK (2004) Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom 18: 1245-1249
12. Cawley AT, Flenker U (2008) The application of carbon isotope ratio mass spectrometry to doping control. J Mass Spectrom 43: 854-864
13. Clasing D (1992) Doping - verbotene Arzneistoffe im Sport. Gustav Fischer Verlag, Stuttgart
14. de la Torre X, Segura J, Yang Z, Li Y, Wu M (1997) Testosterone detection in different ethnic groups. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Proceedings of the 14th Cologne Workshop on Dope Analysis 1996. Sport und Buch Strauß, Cologne, pp 71-89
15. Donike M (1969) N-Methyl-Ntrimethylsilyl- trifluoracetamid, ein neues Silylierungsmittel aus der Reihe der silylierten Amide. J Chromatogr 42: 103-104
16. Donike M, Bärwald KR, Klostermann K, Schänzer W, Zimmermann J (1983) Nachweis von exogenem Testosteron. In:HeckH, HollmannW, Liesen W, Rost R (eds) Sport: Leistung und Gesundheit. Deutscher Ärzte Verlag, Cologne, pp 293-298
17. Donike M, Zimmermann J, Bärwald KR, Schänzer W, Christ V, Klostermann K, Opfermann G (1984) Routine Bestimmung von Anabolika im Harn. Deutsch Z Sportmed 1: 14-23
18. Donike M, Ueki M, Kuroda Y, Geyer H, Nolteernsting E, Rauth S, Schänzer W, Schindler U, Völker E, Fujisaki M (1995) Detection of dihydrotestosterone (DHT) doping: alteration in the steroid profile and reference ranges for DHT and its 5a-metabolites. J Sports Med Phys Fitness 35: 235-250
19. Duchaine D (1989) Underground Steroid Handbook II. Technical Books, Venice, FL
20. Flenker U, Güntner U, Schänzer W (2008) Delta13C-values of endogenous urinary steroids. Steroids 73: 408-416
21. Franke WW, Berendonk B (1997) Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43: 1262-1279
22. Gao W, Dalton JT (2007) Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today 12: 241-248
23. Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schänzer W (2004) Analysis of non-hormonalnutritional supplements for anabolic-androgenic steroids - results of an international study. Int J Sports Med 25: 124-129
24. Grundig P, Bachmann M (1995) World Anabolic Review 1996. Sport Verlag Ingenohl, Heilbronn
25. Handelsman DJ, Gupta L (1997) Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students. Int J Androl 20: 159-164
26. Haupt HA, Rovere GD (1984) Anabolic steroids: a review of the literature. Am J Sports Med 12: 469-484
27. Horning S, Geyer H, Machnik M, Schänzer W, Hilkert A, Oeßelmann J (1997) Detection of exogenous testosterone by 13C/12C analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck-Engelke U (eds) Proceedings of the 14th Cologne Workshop on Dope Analysis 1996. Sport und Buch Strauß, Cologne, pp 275-283
28. Kamber M (1995) Mitteilung in Doping - Information und Prävention. Maggelingen 7: 4-7
29. Kazlauskas R (2010) Designer steroids. In: Thieme D, Hemmersbach P (eds) Doping in Sports. Handbook of Experimental Pharmacology, Vol. 195, Springer, Heidelberg, pp 155-185
30. Kicman AT, Coutts SB, Walker CJ, Cowan DA (1995) Proposed confirmatory procedure for detecting 5a-dihydrotestosterone doping in male athletes. Clin Chem 41: 1617-1627
31. Kicman AT, Bassindale T, Cowan DA, Dale S, Hutt AJ, Leeds AR (2003) Effect of androstenedione ingestion on plasma testosterone in young women; a dietary supplement with potential health risks. Clin Chem 49: 167-169
32. Kilbourne EJ, Moore WJ, Freedman LP, Nagpal S (2007) Selective androgen receptor modulators for frailty and osteoporosis. Curr Opin Investig Drugs 8: 821-829
33. Kochakian CD (1976) Anabolic- Androgenic Steroids. Springer- Verlag, Berlin Kochakian CD (1990) A steroid review: metabolite of testosterone; significance in the vital economy. Steroids 55: 92-97
34. Leder BZ, Longcope C, Catlin DC, Ahrens B, Schoenfeld DA, Finkelstein JS (2000) Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 283: 779-782
35. Massé R, Ayotte C, Dugal R (1989) Integrated methodological approach to the gas chromatographic mass spectrometric analysis of anabolic steroid metabolites in urine. J Chromatogr 489: 23-50
36. Miller CP, Bhaket P, Muthukaman N, Lyttle CR, Shomali M, Gallacher K, Slocum C, Hattersley G (2010) Synthesis of potent, substituted carbazoles as selective androgen receptor modulators (SARMs). Bioorg Med Chem Lett 20: 7516-7520
37. Mohler ML, Bohl CE, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD (2008) Nonsteroidal tissue-selective androgen receptor modulators. In: Ottow E, Weinmann H (eds) Nuclear Receptors as Drug Targets. Wiley-VCH, Weinheim, pp 249-304
38. Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD (2009) Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 52: 3597-3617
39. Nagata N, Miyakawa M, Amano S, Furuya K, Yamamoto N, Inoguchi K (2011) Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs). Bioorg Med Chem Lett 21: 1744-1747
40. Parr MK, SchänzerW(2010) Detection of the misuse of steroids in doping control. J Steroid Biochem Mol Biol 121: 528-537
41. Schänzer W (1996) Review - metabolism of anabolic androgenic steroids. Clin Chem 42: 1001-1020
42. Schänzer W, Donike M (1993) Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Anal Chim Acta 275: 23-48
43. Schänzer W, Delahaut P, Geyer H, Machnik M, Horning S (1996) Longterm detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography/high resolution mass spectrometry (GC/HRMS). J Chormatogr B 687: 93-108
44. Schänzer W, Geyer H, Fußhöller G, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M (2006) Mass spectrometric identification and characterization of a new long-term metabolite of metandienone. Rapid Commun Mass Spectrom 10: 2252-2258
45. Schmidt A, Kimmel DB, Bai C, Scafonas A, Rutledge S, Vogel RL, McElwee-Witmer S, Chen F, Nantermet PV, Kasparcova V, Leu CT, Zhang HZ, Duggan ME, Gentile MA, Hodor P, Pennypacker B, Masarachia P, Opas EE, Adamski SA, Cusick TE, Wang J, Mitchell HJ, Kim Y, Prueksaritanont T, Perkins JJ, Meissner RS, Hartman GD, Freedman LP, Harada S, Ray WJ (2010) Discovery of the selective androgen receptor modulator MK- 0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiology. J Biol Chem 285: 17054-17064
46. Schrader Y, Thevis M, Schänzer W (2006) Quantitative determination of metabolic products of 19- norandrostenediol in human plasma using gas chromatography/mass spectrometry. Drug Metab Dispos 34: 1328-1335
47. Sekera MH, Ahrens BD, Chang YC, Starcevic B, Georgakopoulos C, Catlin DH (2005) Another designer steroid: discovery, synthesis, and detection of ‘madol’ in urine. Rapid Commun Mass Spectrom 19: 781-784
48. Shackleton CH, Phillips A, Chang T, Li Y (1997) Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids 62: 379-387
49. Sinner D (2009) Anabole Steroide - Das Schwarze Buch 2010. BMS Verlag, Gronau, Germany
50. Striegel H, Simon P, Frisch S, Roecker K, Dietz K, Dickhuth HH, Ulrich R (2006) Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend 81: 11-19
51. Taylor WN (1982) Steroids and the Athlete. McFarland & Company, London
52. Thevis M, Schänzer W (2008) Mass spectrometry of selective androgen receptor modulators. J Mass Spectrom 43: 865-876
53. Thevis M, SchänzerW(2010) Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators. In: Thieme D, Hemmersbach P (eds) Doping in Sports. Handbook of Experimental Pharmacology, Vol. 195. Springer, Heidelberg, pp 99-126
54. Thevis M, Opfermann G, Schmickler H, Schänzer W (2001) Mass spectrometry of steroid glucuronide conjugates. I. Electron impact fragmentations of 5a-/5bandrostan- 3a-ol-17-one glucuronides, 5a-estran-3a-ol-17- one glucuronide and deuteriumlabelled analogues. J Mass Spectrom 36: 159-168
55. Thevis M, Kamber M, Schänzer W (2006) Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun Mass Spectrom 20: 870-876
56. Thevis M, Kohler M, Maurer J, Schlörer N, Kamber M, Schänzer W (2007a) Screening for 2- quinolinone-derived selective androgen receptor agonists in doping control analysis. Rapid Commun Mass Spectrom 21: 3477-3486
57. Thevis M, Kohler M, Schänzer W (2007b) Mass spectrometry of new growth promoting drugs: hydantoin-derived selective androgen receptor modulators and growth hormone secretagogues. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds) Recent Advances in Doping Analysis. Sport und Buch Strauß, Cologne, pp 263-272
58. Thevis M, Kohler M, Schlörer N, Fusshöller G, Schänzer W (2008a) Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis. Eur J Mass Spectrom (Chichester, Eng) 14: 153-161
59. Thevis M, Kohler M, Thomas A, Schlörer N, Schänzer W (2008b) Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 22: 2471-2478
60. Thevis M, Lohmann W, Schrader Y, Kohler M, Bornatsch W, Karst U, Schänzer W (2008c) Use of an electrochemically synthesized metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing. Eur J Mass Spectrom (Chichester, Eng) 14: 163-170
61. Thevis M, Geyer H, Kamber M, Schänzer W (2009) Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a blackmarket product. Drug Test Anal 1: 387-392
62. Thevis M, Thomas A, Fusshöller G, Beuck S, Geyer H, Schänzer W (2010) Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. Rapid Commun Mass Spectrom 24: 2245-2254
63. Thevis M, Geyer H, Thomas A, Schänzer W (2011) Trafficking of drug candidates relevant for sports drug testing: detection of nonapproved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet. Drug Test Anal 3: 331-336
64. Thomas A, Guddat S, Kohler M, Krug O, Schänzer W, Petrou M, Thevis M (2010) Comprehensive plasmascreening for known and unknown substances in doping controls. Rapid Commun Mass Spectrom 24: 1124-1132
65. WADA (2010) The 2010 Prohibited List. World Anti-Doping Agency, Montreal. Available at: www.wadaama.org/Documents/World_Anti-Doping_Program/WADPProhibited-list/WADA_Prohibited_List_2010_EN. pdf (accessed Jan 14, 2010)
66. Wade N (1972) Anabolic steroids: doctors denounce them, but athletes aren’t listening. Science 176: 1399-1403
67. Ward RJ, Lawson AM, Shackleton CHL (1975) Screening by gas chromatography-mass spectrometry for metabolites of five commonly used anabolic steroid drugs. Br J Sports Med 9: 93-97
68. Wilson JD (1988) Androgen abuse by athletes. Endocr Rev 9: 191-199
69. Wilson JD (1996) Androgens. In: Hardmann JG, Limbird IE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th edn. McGraw Hill, New York, pp 1441-1457
70. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS (1993) Anabolicandrogenic steroid use in the United States. JAMA 270: 1217-1221
71. Zimmermann J (1986) Untersuchungen zum Nachweis von exogenen Gaben von Testosterone. Thesis, German Sports University, Cologne. Hartung-Gorre Verlag, Konstanz